Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 season

Trial Identifier: D2560C00012
Sponsor: MedImmune, LLC
Collaborator:
AstraZeneca
NCTID:: NCT02743117
Start Date: May 2016
Primary Completion Date: November 2016
Study Completion Date: November 2016
Condition: Healthy Volunteers; Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, FL South Miami, FL, United States of America, 33143
United States of America, GA Stockbridge, GA, United States of America, 30281
United States of America, OR Portland, OR, United States of America, 97239